Next Article in Journal
How Can Operational Research Help to Eliminate Tuberculosis in the Asia Pacific Region?
Next Article in Special Issue
Antimicrobial Resistance (AMR) in the Food Chain: Trade, One Health and Codex
Previous Article in Journal
Investigation of Mixture Modelling Algorithms as a Tool for Determining the Statistical Likelihood of Serological Exposure to Filariasis Utilizing Historical Data from the Lymphatic Filariasis Surveillance Program in Vanuatu
Previous Article in Special Issue
Japanese Encephalitis Virus in Australia: From Known Known to Known Unknown
Article Menu

Export Article

Open AccessArticle

Insights into Australian Bat Lyssavirus in Insectivorous Bats of Western Australia

School of Veterinary Medicine, Murdoch University, Perth, WA 6150, Australia
Australian Animal Health Laboratory, CSIRO, Geelong, VIC 3220, Australia
Author to whom correspondence should be addressed.
These authors contributed equally.
Trop. Med. Infect. Dis. 2019, 4(1), 46;
Received: 21 February 2019 / Revised: 7 March 2019 / Accepted: 7 March 2019 / Published: 11 March 2019
(This article belongs to the Special Issue One Health and Zoonoses)
PDF [1195 KB, uploaded 11 March 2019]


Australian bat lyssavirus (ABLV) is a known causative agent of neurological disease in bats, humans and horses. It has been isolated from four species of pteropid bats and a single microbat species (Saccolaimus flaviventris). To date, ABLV surveillance has primarily been passive, with active surveillance concentrating on eastern and northern Australian bat populations. As a result, there is scant regional ABLV information for large areas of the country. To better inform the local public health risks associated with human-bat interactions, this study describes the lyssavirus prevalence in microbat communities in the South West Botanical Province of Western Australia. We used targeted real-time PCR assays to detect viral RNA shedding in 839 oral swabs representing 12 species of microbats, which were sampled over two consecutive summers spanning 2016–2018. Additionally, we tested 649 serum samples via Luminex® assay for reactivity to lyssavirus antigens. Active lyssavirus infection was not detected in any of the samples. Lyssavirus antibodies were detected in 19 individuals across six species, with a crude prevalence of 2.9% (95% CI: 1.8–4.5%) over the two years. In addition, we present the first records of lyssavirus exposure in two Nyctophilus species, and Falsistrellus mackenziei. View Full-Text
Keywords: Australian bat lyssavirus; microbats; Western Australia; serology; Luminex; real-time PCR Australian bat lyssavirus; microbats; Western Australia; serology; Luminex; real-time PCR

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Supplementary material


Share & Cite This Article

MDPI and ACS Style

Prada, D.; Boyd, V.; Baker, M.; Jackson, B.; O’Dea, M. Insights into Australian Bat Lyssavirus in Insectivorous Bats of Western Australia. Trop. Med. Infect. Dis. 2019, 4, 46.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Metrics

Article Access Statistics



[Return to top]
Trop. Med. Infect. Dis. EISSN 2414-6366 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top